balsalazide disodium
NDC 70710-1626, balsalazide disodium, capsule, from Zydus Pharmaceuticals (USA) Inc..
- Product NDC
- 70710-1626
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217592
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BALSALAZIDE DISODIUM750 mg/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1626-1 | 70710162601 | 280 CAPSULE in 1 BOTTLE (70710-1626-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0ed73067-e2ca-4184-a93a-5a2141bb4898NADAC price for package 70710162601
GET /v1/drugs/nadac/70710162601
Use it
Look up 70710-1626 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.